Literature DB >> 31721134

Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management.

Kalliopi J Ioakim1, Guy I Sydney1, Stavroula A Paschou2,3.   

Abstract

The aim of this review is to explore and discuss disorders of glucose metabolism that can arise in individuals with adrenal gland disorders, as well as to enumerate the available therapeutic treatments for these while considering their benefits and drawbacks. Hyperfunctioning adrenal glands, as in hypercortisolism, hyperaldosteronism, and malignancy, or hypofunctioning of adrenal glands, as in adrenal insufficiency, can lead to carbohydrate metabolism dysregulation with subsequent glucometabolic repercussions, either hyperglycemia or hypoglycemia. Glycemic disorders further affect patients' quality of life and represent a therapeutic dilemma for physicians. Current management strategies for glycemic dysregulation in individuals with adrenal gland disorders are fighting the underlying causes, as well as utilizing antidiabetic therapies that aid in maintaining euglycemia. Further research focused on discovering drug preparations of greater accuracy and effectiveness tailored to patients with adrenal problems as well as studies investigating optimal lifestyle management models for these individuals will assist towards achieving optimal regulation of glucose metabolism.

Entities:  

Keywords:  Adrenal; Antidiabetic medications; Hyperglycemia; Hypoglycemia; Incidentalomas; Insulin resistance; Type 2 diabetes

Mesh:

Year:  2019        PMID: 31721134     DOI: 10.1007/s42000-019-00147-z

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  3 in total

Review 1.  Secondary diabetes mellitus due to primary aldosteronism.

Authors:  Melpomeni Moustaki; Stavroula A Paschou; Eleni C Vakali; Andromachi Vryonidou
Journal:  Endocrine       Date:  2022-08-24       Impact factor: 3.925

Review 2.  An Overview of Hypoglycemia in Children Including a Comprehensive Practical Diagnostic Flowchart for Clinical Use.

Authors:  Alberto Casertano; Alessandro Rossi; Simona Fecarotta; Francesco Maria Rosanio; Cristina Moracas; Francesca Di Candia; Giancarlo Parenti; Adriana Franzese; Enza Mozzillo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-02       Impact factor: 5.555

Review 3.  The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.

Authors:  Abdolkarim Mahrooz; Giovanna Muscogiuri; Raffaella Buzzetti; Ernesto Maddaloni
Journal:  Endocrine       Date:  2021-04-22       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.